Molnupiravir, also known by its brand name Lagevrio, represents a significant advancement in the effort against COVID-19. This taken by mouth antiviral compound works by introducing errors into the virus's genetic sequence, effectively halting its replication and progression within the patient. While initial data suggested a significant reduction i